BEGIN:VCALENDAR VERSION:2.0 PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4// BEGIN:VEVENT UID:20250818T232433EDT-6373UcGUWk@132.216.98.100 DTSTAMP:20250819T032433Z DESCRIPTION:McIntyre Medical Building\, 3655 promenade Sir William Osler\n \nRoom 1345\n\nDr. Uri Saragovi\, Professor\, Dept. of Pharmacology Lady D avis Institute Jewish General Hospital Room E-535\, 3999 Cote Ste Catherin e Montreal\, QC H3T 1E2 \n\nSeminar Title: 'Drug Development and Academic Translational Medicine:  from target discovery and validation\, to experim ental therapeutics'\n\nPharmaceutical industry has shifted their model fro m drug and target discovery to clinical development.  To maintain a pipeli ne\, they rely on biotechnology and on academic researchers.  This has cre ated an opportunity to engage in creative research with a translational co mponent that can benefit academia\, industry\, patients\, and society at l arge.  However\, academics must approach target discovery\, drug discovery \, and translational medicine in ways that differ significantly from appro aches used by industry.\n I will present our experience in applying concept s pertinent to academic research that have lead to discovery and validatio n of novel targets etiological to disease states\, and the subsequent deve lopment of novel compounds acting as agonists or as antagonists of the nov el targets\n Depending on time\, I will show specific examples of our work on\n *  receptor tyrosine kinases -TrkA\, TrkB\, TrkC- applied to neurodege nerative diseases\n *  receptors with pro-apoptotic function -p75NTR- appli ed to neurodegenerative diseases and vascular diseases.\n *  cancer vaccine s\n The good news is that it is possible to engage in translational researc h. However\, this is not an easy endeavor\, and significant challenges exi st. Overcoming the obstacles require a strong collaborative environment an d high quality hypothesis-driven science.\n\n \n DTSTART:20160926T160000Z DTEND:20160926T170000Z SUMMARY:Dr. Uri Saragovi\, 'Drug Development and Academic Translational Med icine: from target discovery and validation to experimental therapeutics' URL:/pharma/channels/event/dr-uri-saragovi-drug-develo pment-and-academic-translational-medicine-target-discovery-and-validation- 262347 END:VEVENT END:VCALENDAR